On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Hospital Universitario Ramón y Cajal

InstitutionResearch output, impact & collaborations

Hospital Universitario Ramón y Cajal is a institution indexed in ScholarIQ from OpenAlex.

What is known about Hospital Universitario Ramón y Cajal?

ScholarIQrecord summary

Hospital Universitario Ramón y Cajal is a research organisation in Madrid, ES. OpenAlex records 25,439 works and 1,400,043 citations for it. 7,079 researchers list it as their most recent affiliation.

How many works does Hospital Universitario Ramón y Cajal have?

ScholarIQindexed works

Hospital Universitario Ramón y Cajal has 25,439 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Hospital Universitario Ramón y Cajal have?

ScholarIQcitation count

Hospital Universitario Ramón y Cajal has 1,400,043 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Hospital Universitario Ramón y Cajal?

ScholarIQresearcher count

Hospital Universitario Ramón y Cajal has 7,079 researchers in the ScholarIQ index.

What is the average h-index at Hospital Universitario Ramón y Cajal?

ScholarIQavg h-index

Hospital Universitario Ramón y Cajal has an average h-index of 40.5 in OpenAlex.

What is the ROR of Hospital Universitario Ramón y Cajal?

ScholarIQror

The ROR for Hospital Universitario Ramón y Cajal is on the source record.

What is the OpenAlex record for Hospital Universitario Ramón y Cajal?

ScholarIQopenalex

The OpenAlex for Hospital Universitario Ramón y Cajal is on the source record.

Who are the most-cited researchers behind Hospital Universitario Ramón y Cajal?

ScholarIQtop researchers by citations
1
Antonio Culebras · Acute Ischemic Stroke Management
259 works18,316 citations
2
Pilar Garrido · Lung Cancer Treatments and Mutations
497 works16,709 citations

What are the most-cited papers on Hospital Universitario Ramón y Cajal?

ScholarIQmost cited works
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell, Enric Carcereny, Radj Gervais, A. Vergnenègre, Bartomeu Massutí, Enriqueta Felip, Ramón Palmero, Ramón García-Gómez, Cinta Pallarés, José Miguel Sánchez, Rut Porta, Manuel Cobo, Pilar Garrido, Flavia Longo, Teresa Morán, Amelia Insa, Filippo de Marinis, R. Corre, Isabel Bover, Alfonso Illiano, Éric Dansin, Javier de Castro, Michèle Milella, Noemı́ Reguart, Giuseppe Altavilla, Ulpiano Jiménez, Mariano Provencio, Miguel Ángel Moreno, Josefa Terrasa, José Muñoz-Langa, Javier Valdivia, Dolores Isla, Manuel Dómine, Olivier Molinier, Julien Mazières, Nathalie Baize, Rosario García‐Campelo, G. Robinet, Delvys Rodríguez‐Abreu, Guillermo López-Vivanco, Vittorio Gebbia, Lioba Ferrera-Delgado, P. Bombaron, Reyes Bernabé, Alessandra Bearz, Á. Artal, Enrico Cortesi, Christian Rolfo, María Sanchez-Ronco, Ana Drozdowskyj, Cristina Queralt, Itziar de Aguirre, José Luis Ramírez, José Javier Sánchez, Miguel Ángel Molina‐Vila, Miquel Tarón, Luis Paz‐Ares
The Lancet Oncology. 20125,545 CitationsOPEN ACCESS
Vascular dementia
Gustavo C. Román, T. K. Tatemichi, Timo Erkinjuntti, Jeffrey L. Cummings, Joseph C. Masdeu, Julio Herrero García, L. Amaducci, J. M. Orgogozo, A. Brun, Albert Hofman, D. M. Moody, M D O’Brien, Takenori Yamaguchi, Jordan Grafman, Burton P. Drayer, David A. Bennett, M Fisher, Jun Ogata, E. Kokmen, F Bermejo, P. A. Wolf, Philip B. Gorelick, Katherine Bick, Aurora K. Pajeau, Martha Ann Bell, Charles DeCarli, Antonio Culebras, Amos D. Korczyn, Julien Bogousslavsky, Anders Hartmann, Peritz Scheinberg
Neurology. 19934,916 Citations
An Updated Definition of Stroke for the 21st Century
Ralph L. Sacco, Scott E. Kasner, Joseph P. Broderick, Louis R. Caplan, John J. Connors, Antonio Culebras, Mitchell S.V. Elkind, Mary G. George, Allen D. Hamdan, Randall T. Higashida, Brian L. Hoh, L. Scott Janis, Carlos S. Kase, Dawn Kleindorfer, Jin‐Moo Lee, Michael E. Moseley, Eric D. Peterson, Tanya N. Turan, Amy L. Valderrama, Harry V. Vinters
Stroke. 20133,534 CitationsOPEN ACCESS
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
Robert C. Doebele, Alexander Drilon, Luis Paz‐Ares, Salvatore Siena, Alice T. Shaw, Anna F. Farago, Collin M. Blakely, Takashi Seto, Byoung Chul Cho, Diégo Tosi, Benjamin Besse, Sant P. Chawla, Lyudmila Bazhenova, John C. Krauss, Young Kwang Chae, Minal Barve, Ignacio Garrido‐Laguna, Stephen V. Liu, Paul Conkling, Thomas John, Marwan Fakih, Darren Sigal, Herbert H. Loong, Gary L. Buchschacher, Pilar Garrido, Jorgé Nieva, Conor Steuer, Tobias R. Overbeck, Daniel W. Bowles, Elizabeth Fox, Todd Riehl, Edna Chow‐Maneval, Brian Simmons, Na Cui, Ann Johnson, Susan Eng, Timothy R. Wilson, George D. Demetri
The Lancet Oncology. 20191,776 CitationsOPEN ACCESS
Sleep Apnea and Cardiovascular Disease
Virend K. Somers, David P. White, Raouf Amin, William T. Abraham, Fernando Costa, Antonio Culebras, Stephen R. Daniels, John S. Floras, Carl E. Hunt, Lyle J. Olson, Thomas G. Pickering, Richard Russell, Mary Woo, Terry Young
Journal of the American College of Cardiology. 20081,491 Citations

How much of the research on Hospital Universitario Ramón y Cajal is open access?

ScholarIQopen access share
80%OPEN ACCESS
Gold
0%
Green
30%
Hybrid
20%
Bronze
30%
Closed
20%

Related on ScholarIQ

470M+ articles · 14-day free trial